RECURRENT NON-MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA
Clinical trials for RECURRENT NON-MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT NON-MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA trials appear
Sign up with your email to follow new studies for RECURRENT NON-MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immunotherapy vs chemo: new hope for bladder cancer patients?
Disease control Recruiting nowThis study compares two treatments for a type of bladder cancer that hasn't spread into the muscle. One group gets the immunotherapy drug pembrolizumab plus radiation, while the other gets standard chemotherapy plus radiation. The goal is to see which combination better prevents …
Matched conditions: RECURRENT NON-MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 16, 2026 12:52 UTC
-
Can a prostate drug slow bladder cancer? new study investigates
Knowledge-focused Recruiting nowThis early-stage trial is testing whether bicalutamide, a drug typically used for prostate cancer, can change a protein linked to bladder cancer growth. About 80 adult men with non-invasive bladder cancer will either receive the drug or no study drug. The goal is to see if the dr…
Matched conditions: RECURRENT NON-MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA
Phase: PHASE1 • Sponsor: University of Wisconsin, Madison • Aim: Knowledge-focused
Last updated Jun 10, 2026 13:25 UTC